Mentor Adjunct Study for Silicone Gel-Filled Mammary Prosthesis

NCT00948948 | Unknown

• 1 other identifier: 0005033
• Study Type: expanded_access
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

Mentor is undertaking a five-year prospective clinical study designed to collect safety data associated with the implantation of its gel-filled mammary prostheses. This study is an "adjunct" study, which will encompass clinical reviews of reconstructive cases in all patients who meet clinical and regulatory criteria for breast reconstruction with gel-filled mammary prostheses. This "adjunct" study will be accomplished under a limited clinical protocol in which specific parameters will be required but with controls somewhat less stringent than those normally required in Investigational Device Exemption (IDE) Trials.

Conditions

Breast Reconstruction

Interventions

Silicone Gel-Filled Mammary Prostheses DEVICE

Mentor Gel-Filled Mammary Prostheses are comprised of a shell made of medical grade silicone elastomer. Gel-filled implant devices manufactured by Mentor will be used in this study: * Gel-filled device which is available in smooth surface and textured surface (Siltex®) * Becker Expander/Mammary Prosthesis which is available in both the smooth and the textured (Siltex) version Both of these devices were originally indicated for both augmentation and reconstruction mammaplasty procedures, however for purposes of this study, indications are for reconstruction only.

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Must be female (genotypical females only), and
• The patient must be willing to follow the study requirements to include:
• Sign the Informed Consent Document before surgery is performed. (If the patient is under the age of consent, the parent or guardian must sign. It is the responsibility of the doctor to determine the state's age of majority.)
• Agree to complete all required follow-up visits.
• For those patients who wish to participate in the Patient Registry: agree to conditions of the Implant Registry and follow the requirements of the Registry program.
• Agree to follow Mentor Standard Operating Procedures for explant analysis in which case the patient may be asked to authorize the sponsor to complete analysis on any study device(s) that may require removal throughout the duration of the study.
• Must be determined by the Investigator and other medical specialists (as required) to be an acceptable candidate for reconstructive breast surgery. General medical condition and history, as well as psychological appropriateness should be considered before surgical intervention, AND
• In the medical opinion of the surgeon conditions must be such that saline implants are deemed unsuitable for the patient. (Patient preference for gel implants is NOT considered a medical condition.) Examples of saline unsuitability are:
• Severe wrinkling of an existing saline implant to the extent that it would be considered a severe deformity (implant must have been in place longer than 6 months)
• Unilateral replacement (opposite breast is gel)
• Tissue or skin is too thin to support a saline implant
• Previously dissected pocket is incompatible with saline implant, AND
• The patient must have one or more of the following breast conditions:
• Post-unilateral or bilateral mastectomy (immediate or delayed) as a result of cancer or other disease process.
• Require reconstruction due to cancer treatments other than mastectomy.

You may not qualify if:

• In addition to general conditions which, in the opinion of the surgeon and/or consulting physicians may exclude a patient from enrollment as a study subject, patients must be excluded if they meet any one of the following conditions.
• Have an abscess or infection anywhere in their body at the time of study entry.
• Be currently pregnant or nursing.
• Be diagnosed as having lupus defined as Systemic Lupus Erythematosus or Discoid Lupus, or scleroderma defined as Progressive Systemic Sclerosis.
• Currently have uncontrolled diabetes or any diseases which are clinically known to impact wound healing ability.
• Demonstrate tissue characteristics which are clinically incompatible with mammaplasty (e.g., tissue damage resulting from radiation, inadequate tissue, compromised vascularity or ulceration).
• Possess any condition or currently be under treatment for any condition, which in the opinion of the Investigator and/or consulting physician(s), may constitute an unwarranted surgical risk.
• Demonstrate psychological characteristics such as inappropriate attitude or motivation, which, in the opinion of the Investigator are incompatible with the risks, involved with the surgical procedure and the prosthesis.
• Unwillingness to undergo any further surgery for revision (if required).

Sponsors & Collaborators

• Mentor Worldwide, LLC: lead

Study Sites (1)

Mentor Worldwide LLC

Santa Barbara, California, 93111, United States

Location

Study Officials

• Sue Schwefel

  Mentor Worldwide, LLC

  STUDY DIRECTOR

Study Design

• Study Type: expanded access
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 8, 2009
• First Posted: July 29, 2009
• Last Updated: April 5, 2013

Record last verified: 2013-04

Locations

US (1)